Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications.
Genome Biol
; 24(1): 118, 2023 05 17.
Article
in En
| MEDLINE
| ID: mdl-37198692
ABSTRACT
Predicting the impact of coding and noncoding variants on splicing is challenging, particularly in non-canonical splice sites, leading to missed diagnoses in patients. Existing splice prediction tools are complementary but knowing which to use for each splicing context remains difficult. Here, we describe Introme, which uses machine learning to integrate predictions from several splice detection tools, additional splicing rules, and gene architecture features to comprehensively evaluate the likelihood of a variant impacting splicing. Through extensive benchmarking across 21,000 splice-altering variants, Introme outperformed all tools (auPRC 0.98) for the detection of clinically significant splice variants. Introme is available at https//github.com/CCICB/introme .
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
RNA Splicing
/
RNA Splice Sites
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Genome Biol
Journal subject:
BIOLOGIA MOLECULAR
/
GENETICA
Year:
2023
Document type:
Article
Affiliation country:
Australia